📋 FDA Reference

Ultraflex Ev Hemostasis Introducer

St. Jude Medical, Inc.

Ask about this device Compare similar devices

Summary: The Ultraflex EV Hemostasis Introducer is a medical device used primarily in vascular procedures to facilitate the introduction of embolization coils. It is typically used by interventional radiologists and cardiologists.

FDA Clearance Information

Pathway ? 510(k)
Number ? K012922 ↗
Decision Date ? September 25, 2001
Product Code ? DYB
Device Class ? Class 2
Evidence ? 0 studies

The Ultraflex EV Hemostasis Introducer was cleared through the FDA 510(k) pathway on September 25, 2001. Manufactured by St Jude Medical, it is classified as a Class 2 device under product code DYB.

What It Is

The Ultraflex EV Hemostasis Introducer is a specialized catheter system designed to provide vascular access and facilitate the delivery of embolization coils. It features a flexible sheath that allows for smooth insertion and navigation within blood vessels, minimizing trauma to the vessel walls. This device is essential in procedures requiring precise placement of embolic materials to control bleeding or occlude blood flow to specific areas.

FDA-Cleared Indications

  • Introduction and delivery of embolization coils during vascular procedures.
  • Vascular access for procedures requiring placement of embolic coils to occlude or control blood flow.

Clinical Applications

  • Delivery of embolization coils for treatment of selected aneurysms and pseudoaneurysms.
  • Delivery of embolization coils to control bleeding from selected gastrointestinal or other vascular sources.
  • Coil embolization of selected arteriovenous malformations or abnormal vascular connections.
  • Coil occlusion of selected visceral, pelvic, or peripheral vessels when vascular embolization is indicated.

Reported off-label uses

  • Use as an access sheath for delivery of other embolic materials or vascular devices when compatible with the catheter system and procedural technique.
  • Use in selected venous embolization procedures, such as varicocele or ovarian-vein embolization, when the device size and configuration are appropriate.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • The appropriate sheath size and length must be selected for the target vessel, access site, guidewire, delivery catheter, and embolization coil system.
  • The device is used with fluoroscopic or other appropriate imaging guidance by clinicians trained in vascular access and embolization.
  • Check compatibility with the intended catheter, guidewire, and coil system before use; do not force the device if resistance is encountered.
  • Potential complications include bleeding, hematoma, arterial or venous injury, thrombosis, infection, vasospasm, embolization to an unintended location, and contrast-related complications.
  • MRI safety and conditional use should be confirmed in the current manufacturer labeling. The FDA record alone does not establish that the device is MR Safe or MR Conditional.

Procedures that use this device

Frequently Asked Questions

What is the Ultraflex EV Hemostasis Introducer used for?

It is used to facilitate the introduction of embolization coils in vascular procedures to control bleeding or occlude blood vessels.

What specialties typically use this device?

Interventional radiologists and cardiologists commonly use this device in procedures requiring vascular access and embolization.

What are the FDA-cleared indications?

The device is indicated for delivering embolization coils to manage bleeding or occlude blood vessels in patients with vascular conditions.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you